Showing results (51-60 of 107) with videos related to
Sort By:
Pageof 11
Arthritis and Rheumatism|November 30, 2006
A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16Michele Mondini, Matteo Vidali, Marco De Andrea, et al.Journal of Hepatology|December 18, 2023
A new clinical and prognostic characterization of the patterns of decompensation of cirrhosisMarta Tonon, Roberta D'Ambrosio, Valeria Calvino, et al.Liver International : Official Journal of the International Association for the Study of the Liver|April 10, 2023
Metabolic dysfunction outperforms ultrasonographic steatosis to stratify hepatocellular carcinoma risk in patients with advanced hepatitis C cured with direct-acting antiviralsSerena Pelusi, Cristiana Bianco, Massimo Colombo, et al.International Journal of Molecular Sciences|April 30, 2014
The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependentRoberta D'Ambrosio, Alessio Aghemo, Raffaele De Francesco, et al.Antiviral Therapy|August 6, 2011
The course of esophageal varices in patients with hepatitis C cirrhosis responding to interferon/ribavirin therapyRoberta D'Ambrosio, Alessio Aghemo, Maria Grazia Rumi, et al.The Journal of Infectious Diseases|September 13, 2023
From Prioritization to Universal Treatment: Successes and Challenges of Hepatitis C Virus Elimination in ItalyLoreta A Kondili, Lucia Craxì, Felice Nava, et al.Plos One|August 30, 2014
Interaction between PNPLA3 I148M variant and age at infection in determining fibrosis progression in chronic hepatitis CStella De Nicola, Paola Dongiovanni, Alessio Aghemo, et al.Development (Cambridge, England)|September 13, 2017
Zfp423/ZNF423 regulates cell cycle progression, the mode of cell division and the DNA-damage response in Purkinje neuron progenitorsFilippo Casoni, Laura Croci, Camilla Bosone, et al.Hepatology (Baltimore, Md.)|September 21, 2011
Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4Stella De Nicola, Alessio Aghemo, Maria Grazia Rumi, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 1, 2023
Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic hepatitis C aged 75 years or older: A multicentre studyNicola Pugliese, Vincenza Calvaruso, Mario Masarone, et al.Pageof 11